{"id":"https://openalex.org/W1935239133","doi":null,"title":"A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.","display_name":"A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.","alternate_titles":[],"publication_year":2001,"publication_date":"2001-12-01","ids":{"openalex":"https://openalex.org/W1935239133","mag":"1935239133","pmid":"https://pubmed.ncbi.nlm.nih.gov/11751482"},"language":"en","primary_location":{"id":"pmid:11751482","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11751482","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W1935239133"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042529049","display_name":"Pankaj Bhargava","orcid":"https://orcid.org/0000-0002-0647-1386","observed_orcids":["https://orcid.org/0000-0002-0647-1386"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P Bhargava","raw_affiliation_strings":["Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA. bhargavp@ummhc.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA. bhargavp@ummhc.org","institution_ids":["https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J L Marshall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J L Marshall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070251705","display_name":"William Dahut","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Dahut","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110476391","display_name":"N. Rizvi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Rizvi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005156838","display_name":"Nina M. Trocky","orcid":"https://orcid.org/0000-0002-3824-2940","observed_orcids":["https://orcid.org/0000-0002-3824-2940"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Trocky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088648956","display_name":"Jon I. Williams","orcid":"https://orcid.org/0000-0002-0410-1250","observed_orcids":["https://orcid.org/0000-0002-0410-1250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J I Williams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062614497","display_name":"Howard I. Hait","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Hait","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101954508","display_name":"Sang Hoon Song","orcid":"https://orcid.org/0000-0002-5084-1137","observed_orcids":["https://orcid.org/0000-0002-5084-1137"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030964615","display_name":"Kenneth J. Holroyd","orcid":"https://orcid.org/0000-0001-6050-3935","observed_orcids":["https://orcid.org/0000-0001-6050-3935"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K J Holroyd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103887854","display_name":"Michael Hawkins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Hawkins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6793,"has_fulltext":false,"cited_by_count":101,"citation_normalized_percentile":{"value":0.90611307,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"7","issue":"12","first_page":"3912","last_page":"3919"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12278","display_name":"Vascular Tumors and Angiosarcomas","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/squalamine","display_name":"squalamine","score":0.9679999947547913},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.8080000281333923},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.7260000109672546},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7720000147819519},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8569999933242798},{"id":"https://openalex.org/keywords/continuous-intravenous-infusion","display_name":"continuous intravenous infusion","score":0.9319999814033508},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.968999981880188},{"id":"https://openalex.org/keywords/transaminase-elevation","display_name":"transaminase elevation","score":0.8619999885559082},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.6230000257492065},{"id":"https://openalex.org/keywords/neuromuscular-toxicity","display_name":"neuromuscular toxicity","score":0.8140000104904175},{"id":"https://openalex.org/keywords/anorexia","display_name":"anorexia","score":0.5460000038146973},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.9240000247955322},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.3109999895095825},{"id":"https://openalex.org/keywords/advanced-lung-cancer","display_name":"advanced lung cancer","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8465875387191772},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7385659217834473},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.5995998382568359},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4892871081829071},{"id":"https://openalex.org/C3018112808","wikidata":"https://www.wikidata.org/wiki/Q640448","display_name":"Continuous infusion","level":2,"score":0.4579019546508789},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.35407835245132446},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3482974171638489},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3424944281578064}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002777","descriptor_name":"Cholestanols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002777","descriptor_name":"Cholestanols","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11751482","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11751482","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:1935239133","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11751482","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1579297325","https://openalex.org/W1758667641","https://openalex.org/W2026151657","https://openalex.org/W2059927830","https://openalex.org/W2081943753","https://openalex.org/W2087100934","https://openalex.org/W2167805334","https://openalex.org/W2168378772","https://openalex.org/W2202508590","https://openalex.org/W2324677651","https://openalex.org/W2399463374","https://openalex.org/W2409767228"],"related_works":["https://openalex.org/W2131204311","https://openalex.org/W4211156056","https://openalex.org/W2168378772","https://openalex.org/W1977320134","https://openalex.org/W4306937113","https://openalex.org/W1920739798","https://openalex.org/W2121432187","https://openalex.org/W2160504394","https://openalex.org/W3011350989","https://openalex.org/W1998384592"],"abstract_inverted_index":{"PURPOSE:":[0],"A":[1,73],"Phase":[2],"I":[3],"study":[4],"of":[5,39,94,122,147,161,170,218,274,285,359,385,393,396,403],"squalamine,":[6],"a":[7,45,282,297,316,338,345,364,382],"novel":[8],"antiangiogenic":[9],"agent":[10],"originally":[11],"isolated":[12],"from":[13,126,255,406],"the":[14,29,111,120,145,250,303,391],"dogfish":[15],"shark":[16],"Squalus":[17],"acanthias,":[18],"was":[19,78,109,113,124,194,278,369],"conducted":[20],"in":[21,64,132,158,288,321,337,417],"patients":[22,65,88,137,162,171,235,373,422],"with":[23,315,340,347,350,398,415,419,423],"advanced":[24],"cancers":[25],"to:":[26],"(a)":[27],"determine":[28],"maximum":[30,272],"tolerated":[31,68,356],"dose":[32,75,83,112,117,143,157,252,283,309,357,383],"(MTD),":[33],"dose-limiting":[34],"toxicity":[35],"(DLT)":[36],"and":[37,53,119,190,206,216,268,307,344,401,428],"pharmacokinetics":[38],"squalamine":[40,142,232,308,319,360,378,416],"lactate":[41],"when":[42,240,253,361],"given":[43],"as":[44,156,363],"120-h":[46,69,152,365],"continuous":[47,61,275,366],"i.v.":[48,62,276,367],"infusion":[49,123,277,368],"every":[50],"two":[51],"weeks;":[52],"(b)":[54],"to":[55,129,312,377,380],"obtain":[56],"information":[57],"on":[58],"prolonged":[59,125,317],"(>120-h)":[60],"infusions":[63,153],"who":[66,150],"have":[67,412],"infusions.":[70],"EXPERIMENTAL":[71],"DESIGN:":[72],"rapid":[74],"escalation":[76],"scheme":[77],"used":[79],"that":[80,105,167,174,226],"permitted":[81],"intrapatient":[82],"escalation.":[84],"Three":[85,234],"or":[86,305],"more":[87],"were":[89,138,154,335],"treated":[90,139,172,242],"at":[91,96,104,140,166,173,196,243,249,281],"each":[92],"dose,":[93],"which":[95],"least":[97],"one":[98,116,289],"patient":[99,290,322,339,346],"started":[100],"treatment":[101],"de":[102,164,200,210],"novo":[103,165,201,211],"dose.":[106],"Once":[107],"DLT":[108,193,248],"encountered,":[110],"decreased":[114],"by":[115,221],"level,":[118],"duration":[121,273],"10":[127],"up":[128,311],"30":[130],"days":[131,229,280],"5-day":[133],"increments.":[134],"RESULTS:":[135],"Nineteen":[136],"eight":[141],"levels;":[144],"number":[146,169],"patients/dose":[148],"level":[149],"received":[151],"[expressed":[155],"mg/m(2)/day":[159,198,208,245,287,387],"(number":[160],"initiated":[163,414],"dose/total":[168],"dose)]:":[175],"6":[176],"(3/3),":[177],"12":[178],"(3/6),":[179],"24":[180],"(1/5),":[181],"48":[182],"(2/6),":[183,187],"96":[184],"(4/10),":[185],"192":[186,286,370],"384":[188,197,244,313,386],"(3/8),":[189],"538":[191,207,256],"(1/5).":[192],"encountered":[195],"(1/3":[199],"patients,":[202,212],"5/8":[203],"total":[204,214],"patients)":[205,215],"(1/1":[209],"4/5":[213],"consisted":[217],"hepatotoxicity,":[219],"characterized":[220],"grade":[222,261,264],"3":[223],"transaminase":[224],"elevations":[225],"resolved":[227],"3-11":[228],"after":[230],"ceasing":[231],"infusion.":[233],"did":[236],"not":[237],"experience":[238],"hepatotoxicity":[239],"first":[241],"but":[246],"developed":[247],"same":[251],"de-escalated":[254],"mg/m(2)/day.":[257],"Other":[258],"toxicities":[259],"included":[260],"1-3":[262],"fatigue,":[263],"1-2":[265],"nausea,":[266],"anorexia,":[267],"neuromuscular":[269],"symptoms.":[270],"The":[271,354],"20":[279],"rate":[284,310,358,384],"without":[291,374,388],"adverse":[292],"effects.":[293],"Pharmacokinetic":[294],"calculations":[295],"revealed":[296],"linear":[298],"relationship":[299],"between":[300],"area":[301],"under":[302],"curve":[304],"Cmax":[306],"mg/m(2)/day,":[314],"terminal":[318],"persistence":[320],"plasma":[323],"(median":[324],"t(1/2)":[325],"=":[326],"18":[327],"h;":[328],"range,":[329],"8-48":[330],"h).":[331],"Transient":[332],"tumor":[333],"responses":[334],"observed":[336],"synovial":[341],"cell":[342],"sarcoma":[343],"breast":[348],"carcinoma":[349],"cutaneous":[351],"metastases.":[352],"CONCLUSIONS:":[353],"best":[355],"administered":[362],"mg/m(2)/day;":[371],"however,":[372],"prior":[375],"exposure":[376],"appeared":[379],"tolerate":[381],"DLT.":[389],"On":[390],"basis":[392],"preclinical":[394],"evidence":[395],"synergy":[397],"cytotoxic":[399],"agents":[400],"demonstration":[402],"human":[404],"safety":[405],"this":[407],"trial,":[408],"additional":[409],"clinical":[410],"trials":[411],"been":[413],"combination":[418],"chemotherapy":[420],"for":[421],"late":[424],"stage":[425],"lung":[426],"cancer":[427],"ovarian":[429],"cancer.":[430]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1935239133","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
